Genelex Corporation Rolls Out Lifesaving DNA Healthcare System
9/13/2012 9:56:41 AM
More...
|
Genelex Corporation Receives First Patent on Business Methods for Pharmacogenetics
8/1/2012 10:25:52 AM
More...
|
Genelex Corporation Release: Coumadin (warfarin) Patients Receive New FDA Information
8/17/2007 11:15:53 AM
More...
|
Genelex Corporation Release: Controversial FDA Panel Approves Drug For Use By Children; New DNA Test Alerts Physicians And Parents To Potential Harm
12/7/2006 11:58:00 AM
More...
|
Genelex Corporation Release: FDA Committee Supports Simple DNA Tests When Patients Are Prescribed Coumadin (Warfarin)
11/21/2006 10:14:34 AM
More...
|
Genelex Corporation Release: DNA Tests Now Available Determine Safe Dosage For Dangerous Drugs, Coumadin And Warfarin
10/4/2006 10:20:20 AM
More...
|
Strattera Safety Helped By DNA Testing, According To FDA Approved Product Labeling Notes Genelex Corporation Founder, Howard Coleman
10/19/2005 5:12:58 PM
More...
|
DNA-Based Personalized Medicine Training Announced By Genelex Corporation
10/19/2005 5:12:58 PM
More...
|
DNA Tests Now Available Reveal Possible Deadly Side Effects; Genelex Corporation Urges Users Of Vioxx, Bextra, Celebrex, Aleve And Others To Check DNA Before Taking Meds
10/19/2005 5:11:51 PM
More...
|
Genelex Corporation Release: Gene Tests Available To Consumers
10/19/2005 5:09:33 PM
More...
|